1-9 of 9
Sabine Brechignac, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bortezomib and High-Dose Melphalan Vs. High-Dose Melphalan As Conditioning Regimen before Autologous Stem Cell Transplantation in De Novo Multiple Myeloma Patients: A Phase 3 Study of the Intergroupe Francophone Du Myelome (IFM 2014-02)

Murielle Roussel, Benjamin Hebraud, MD, Valerie Lauwers-Cances, MD, Margaret Macro, MD, Xavier Leleu, MD PhD, Cyrille Hulin, MD, Lionel Karlin, MD, Bruno Royer, MD, Aurore Perrot, MD, Philippe Moreau, MDPhD, Denis Caillot, MD, Sophie Rigaudeau, MD, Mamoun Dib, MD, Emmanuelle Nicolas-Virelizier, MD, Martine Escoffre-Barbe, MD, Karim Belhadj, MD, Brigitte Pegourie, MD, Anne-Marie Stoppa, MD, Carla Araujo, MD, Chantal Doyen, MD, Jean Fontan, MD, Brigitte Kolb, MD, Laurent Garderet, MD PhD, Sabine Brechignac, MD, Jean Valere Malfuson, MD, Veronique Dorvaux, MD, Pascal Lenain, MD, Omar Benbrahim, MD, Arnaud Jaccard, Cecile Borel, MD, Herve Avet Loiseau, MD PhD, Michel Attal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 398.
https://doi.org/10.1182/blood.V130.Suppl_1.398.398
Published: 2017
Journal Articles

Daratumumab in Combination with Dexamethasone in Resistant or Refractory Multiple Myeloma: Primary Results of the IFM2014-04 Trial

Eileen Mary Boyle, MD MSc, Marie-Odile Petillon, MD, Charles Herbaux, MD, Johanna Mimouni, Xavier Leleu, Lionel Karlin, MD, Chantal Doyen, MD, Marc Wetterwald, MD PhD, Muriel Roussel, MD, Cyrille Hulin, Bruno Royer, MD, Margaret Macro, Philippe Moreau, Karel Fostier, MD, Mamoun Dib, Sabine Brechignac, MD, Caroline Bureau, Gerald Marit, MD, Adrian Tempescul, MD, Marie Lorraine Chretien, Charles Zarnitsky, Cecile Fohrer, MD, Aurore Perrot, MD, Lotfi Benboubker, MD PhD, Laurent Voillat, Jean Valere Malfuson, Clara Mariette, Mourad Tiab, Sophie Rigaudeau, Arnaud Jaccard, MD PhD, Anne-Marie Stoppa, Laure Vincent, Jean Claude Eisenmann, MD, Laurent Frenzel, Bertrand Arnulf, MD, Mohamad Mohty, MD PhD, Philippe Rodon, MD, Brigitte Kolb, Olivier Decaux, MD PhD, Pascal Godmer, David Beauvais, Benjamin Carpentier, Sarah Bonnet, MD, Thomas Longval, Mathieu Dewevre, Herve Avet-Loiseau, MD PhD, Michel Attal, Susanna Schraen, PharmD, Thierry Facon
Journal: Blood
Blood (2016) 128 (22): 2138.
https://doi.org/10.1182/blood.V128.22.2138.2138
Published: 2016
Journal Articles

Long Term Follow-up of Hematopoietic Stem Cell Transplantation (HSCT) for Primary Plasma Cell Leukemia (pPCL): Final Results of a Prospective Study of IFM Group

Bruno Royer, MD, Momar Diouf, Murielle Roussel, Lionel Karlin, MD, Cyrille Hulin, Bertrand Arnulf, MD, Margaret Macro, Sylvie Cailleres, Annie Brion, MD, Sabine Brechignac, MD, Karim Belhadj, MD, Marie Lorraine Chretien, Marc Wetterwald, MD PhD, Carine Chaleteix, Mourad Tiab, Xavier Leleu, Laurent Frenzel, Laurent Garderet, MD, Sylvain Choquet, MD, jean Gabriel Fuzibet, Charles Dauriac, MD, luc-Matthieu Fornecker, Lotfi Benboubker, MD PhD, Thierry Facon, MD, Philippe Moreau, Herve Avet Loiseau, MD PhD, Stephane Minvielle, Jean Pierre Marolleau, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4612.
https://doi.org/10.1182/blood.V128.22.4612.4612
Published: 2016
Journal Articles

Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial

Herve Avet-Loiseau, MD PhD, Jill Corre, Valerie Lauwers-Cances, MD, Marie-Lorraine Chretien, Nelly Robillard, Engineer, Xavier Leleu, MD PhD, Cyrille Hulin, MD, Catherine Gentil, Engineer, Bertrand Arnulf, Karim Belhadj, MD, Sabine Brechignac, MD, Laurent Garderet, MD, Lionel Karlin, Gerald Marit, Lotfi Benboubker, Frederique Orsini-Piocelle, MD, Bruno Royer, MD, Bernard Drenou, MD, Mourad Tiab, MD, Thierry Lamy, MD PhD, Margaret MACRO, MD, Paul G. Richardson, MD, Kenneth C Anderson, MD, Malek Faham, MD PhD, Thierry Facon, Philippe Moreau, Michel Attal, Nikhil C. Munshi, MD
Journal: Blood
Blood (2015) 126 (23): 191.
https://doi.org/10.1182/blood.V126.23.191.191
Published: 2015
Journal Articles

Bortezomib, Thalidomide and Dexamethasone (VTD) Is Superior to Bortezomib, Cyclophosphamide and Dexamethasone (VCD) Prior to Autologous Stem Cell Transplantation for Patients with De Novo Multiple Myeloma. Results of the Prospective IFM 2013-04 Trial

Philippe Moreau, Cyrille Hulin, Margaret MACRO, MD, Denis Caillot, Carine Chaleteix, Murielle Roussel, Laurent Garderet, MD, Bruno Royer, MD, Sabine Brechignac, MD, Mourad Tiab, MD, Mathieu Puyade, MD, Martine Escoffre, Anne-Marie Stoppa, MD, Thierry Facon, Brigitte Pégourie, Driss Chaoui, MD, Arnaud Jaccard, MD PhD, Borhane Slama, Gerald Marit, Kamel Laribi, Pascal Godmer, MD, Odile Luycx, Jean Claude Eisenmann, MD, Olivier Allangha, Sylvie Glaisner, Mamoun Dib, Carla Araujo, Jean Fontan, Karim Belhadj, MD, Marc Wetterwald, MD PhD, Veronique Dorvaux, Jean-Paul Fermand, Philippe Rodon, MD, Brigitte Kolb, Pascal Lenain, MD, Lucie Planche, Laetitia Biron, Helene Caillon, Herve Avet-Loiseau, Thomas Dejoie, Michel Attal
Journal: Blood
Blood (2015) 126 (23): 393.
https://doi.org/10.1182/blood.V126.23.393.393
Published: 2015
Journal Articles

Salvage Therapy Post Pomalidomide-Based Regimen in Relapsed/Refractory Myeloma

Guillemette Fouquet, Lionel Karlin, Margaret MACRO, MD, Denis Caillot, Murielle Roussel, Bertrand Arnulf, Brigitte Pégourie, Marie-Odile Petillon, Gerald Marit, Claire Mathiot, MD, Brigitte Kolb, Anne-Marie Stoppa, MD, Sabine Brechignac, MD, Philippe Rodon, MD, Mamoun Dib, Mourad Tiab, MD, Laurence Legros, MD, Anne Banos, MD, Marc Wetterwald, MD PhD, Laurent Garderet, MD, Bruno Royer, MD, Cyrille Hulin, Lotfi Benboubker, Olivier Decaux, MD PhD, Martine Escoffre, Jean-Paul Fermand, Philippe Moreau, Herve Avet-Loiseau, MD PhD, Michel Attal, Thierry Facon, Xavier Leleu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1831.
https://doi.org/10.1182/blood.V126.23.1831.1831
Published: 2015
Journal Articles

Hevylite® to Monitor Response to Therapy in Multiple Myeloma

Guillemette Fouquet, MD, Susanna Schraen, MD, Jean-Luc Faucompré, MD, Lionel Karlin, Margaret Macro, MD, Cyrille Hulin, MD, Brigitte Onraed, MD, Laurent Garderet, MD, Murielle Roussel, MD, Bertrand Arnulf, Brigitte Pegourie, MD, Brigitte Kolb, Anne-Marie Stoppa, MD, Sabine Brechignac, MD, Mauricette Michallet, MD PhD, Gerald Marit, Claire Mathiot, MD, Anne Banos, MD, Mourad Tiab, MD, Mamoun Dib, Jean-Gabriel Fuzibet, MD, Marie-Odile Petillon, MD, Philippe Rodon, MD, Marc Wetterwald, MD PhD, Bruno Royer, MD, Laurence Legros, MD, Lofti Benboubker, MD, Olivier Decaux, Denis Caillot, MD, Martine Escoffre-Barbe, MD, Jean-Paul Fermand, MD, Philippe Moreau, MD, Michel Attal, Hervé Avet-Loiseau, Thierry Facon, MD, Xavier Leleu, MD
Journal: Blood
Blood (2014) 124 (21): 2021.
https://doi.org/10.1182/blood.V124.21.2021.2021
Published: 2014
Journal Articles

Positive Impact of Iron Chelation Therapy (CT) on Survival in Regularly Transfused MDS Patients. A Prospective Analysis by the GFM.

Christian Rose, MD, Sabine Brechignac, MD, Dominique Vassilief, MD, Odile Beyne-Rauzy, MD, A. Stamatoullas, MD, Dalila Larbaa, MD, Agnes Guerci, MD, L. Roy, MD, Lydia Dumazert, MD, Beatrice Mahe, MD, S. Cheze, MD, Bruno Quesnel, MD PD, Dominique Bordessoule, MD PD, Francois Dreyfus, MD PD, Pierre Fenaux, MD PD
Journal: Blood
Blood (2007) 110 (11): 249.
https://doi.org/10.1182/blood.V110.11.249.249
Published: 2007
Journal Articles

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Charikleia Kelaidi, MD, Sophie Park, MD, Sabine Brechignac, MD, Lionel Mannone, MD, Norbert Vey, MD, Herve Dombret, MD, Lina Aljassem, MD, Aspasia Stamatoullas, MD, Lionel Adès, MD, Stéphane Giraudier, MD, Stéphane de Botton, MD, Béatrice Mahé, MD, Pascale Lepelley, MD, Françoise Picard, MD, Geneviève Leroux, MD, Marie-Thérèse Daniel, MD, Didier Bouscary, MD, François Dreyfus, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2006) 108 (11): 2678.
https://doi.org/10.1182/blood.V108.11.2678.2678
Published: 2006